Skip to main navigation Skip to search Skip to main content

Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial

  • P.R. Feldman*
  • , K.M. Fiebig*
  • , C. Piwko
  • , B.M. Mints
  • , D. Brown
  • , D.J. Cahan
  • , J. Guevara-Aguirre
    • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science